全球黑色素瘤疾病负担:2015年全球疾病负担研究结果
该研究基于2015年全球疾病负担研究,评估全球、区域和国家黑色素瘤的发病率、死亡率和伤残调整生命年(DALY)。结果显示负担最重的五个区域为澳大拉西亚、北美、东欧、西欧和中欧,除撒哈拉以南非洲外男性DALY和死亡率均高于女性,DALY率在75-79岁、70-74岁和≥80岁年龄组最高。
要点
- 黑色素瘤负担最重的地区为澳大拉西亚、北美及欧洲多个区域。
- 除撒哈拉以南非洲外,男性DALY和死亡率均高于女性。
- DALY率最高的年龄组为75-79岁、70-74岁和≥80岁。
核心结论
- 全球黑色素瘤负担在区域、年龄和性别间存在显著差异,澳大拉西亚、北美、欧洲、老年和男性人群负担最重。
研究设计与样本
- 利用生命登记系统和癌症登记数据进行死亡率建模,并通过单独建模的死亡率-发病率比估算发病率和患病率。
主要发现
- 发病率、DALY率和死亡率最高的五个世界区域为澳大拉西亚、北美、东欧、西欧和中欧。
- 除撒哈拉以南非洲区域外,男性和女性的DALY率与死亡率均表现为男性更高。
- 按年龄的DALY率在75-79岁、70-74岁和≥80岁人群最高。
关键数值与推荐
- 总患病率被分为四个疾病阶段并乘以残疾权重生成伤残损失健康生命年(YLDs)。
- 各年龄组死亡数乘以参考预期寿命生成寿命损失年(YLLs),YLDs与YLLs相加估算DALYs。
临床怎么用
- 研究结果可帮助制定黑色素瘤研究和公共政策,并提示需在负担最重的人群中加强预防措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite recent improvements in prevention, diagnosis and treatment, vast differences in melanoma burden still exist between populations. Comparative data can highlight these differences and lead to focused efforts to reduce the burden of melanoma. OBJECTIVES: To assess global, regional and national melanoma incidence, mortality and disability-adjusted life year (DALY) estimates from the Global Burden of Disease Study 2015. METHODS: Vital registration system and cancer registry data were used for melanoma mortality modelling. Incidence and prevalence were estimated using separately modelled mortality-to-incidence ratios. Total prevalence was divided into four disease phases and multiplied by disability weights to generate years lived with disability (YLDs). Deaths in each age group were multiplied by the reference life expectancy to generate years of life lost (YLLs). YLDs and YLLs were added to estimate DALYs. RESULTS: The five world regions with the greatest melanoma incidence, DALY and mortality rates were Australasia, North America, Eastern Europe, Western Europe and Central Europe. With the exception of regions in sub-Saharan Africa, DALY and mortality rates were greater in men than in women. DALY rate by age was highest in those aged 75-79 years, 70-74 years and ≥ 80 years. CONCLUSIONS: The greatest burden from melanoma falls on Australasian, North American, European, elderly and male populations, which is consistent with previous investigations. These substantial disparities in melanoma burden worldwide highlight the need for aggressive prevention efforts. The Global Burden of Disease Study results can help shape melanoma research and public policy.
引用
- Karimkhani C, Green AC, Nijsten T, et al. The global burden of melanoma: results from the Global Burden of Disease Study 2015. Br J Dermatol. 2017. PMID: 28369739. doi:10.1111/bjd.15510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。